S
CLS icon

SharpePoint’s Celestica CLS Stock Holding History

SharpePoint’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Sell
9,281
-22
-0.2% -$8.26K 1.7% 21
2026
Q1 		$2.62M Buy
9,303
+273
+3% +$79.2K 1.56% 26
2025
Q4 		$2.67M Sell
9,030
-2,567
-22% -$774K 1.6% 22
2025
Q3 		$2.86M Sell
11,597
-6,721
-37% -$1.36M 2.58% 16
2025
Q2 		$2.86M Sell
18,318
-197
-1% -$20.9K 2.94% 13
2025
Q1 		$1.61M Buy
+18,515
New +$1.96M 1.41% 29

Other funds holding CLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SharpePoint's CLS Position: Q2 2026 in Review

SharpePoint reduced its Celestica (CLS) stake by 0.24% in Q2 2026, selling an estimated $8.26K and leaving 9,281 shares worth $3.39M. The position accounts for 1.7% of the portfolio, ranked #21.

SharpePoint first reported a position in CLS in Q1 2025 and has held it in 6 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • SharpePoint held 9,281 shares of Celestica worth $3.39M as of Q2 2026.
  • SharpePoint sold 22 Celestica shares in Q2 2026, an estimated $8.26K.
  • Celestica made up 1.7% of SharpePoint's portfolio in Q2 2026, its #21 holding.
  • SharpePoint first reported a position in Celestica in Q1 2025 and has held it in 6 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on SharpePoint's 13F filing for Q2 2026, filed 29 Jul 2026.